D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
EVLO holding history
Evelo Biosciences, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EVLO overviewAll 13F holders of EVLOFull Q2 2026 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −19,205−100.0% | Sold out | Holders |
| Q2 2022 | 19,205 | $41.0K | <0.1% | −3,730−16.3% | Reduced | Holders |
| Q1 2022 | 22,935 | $78.0K | <0.1% | +22,935 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −33,774−100.0% | Sold out | Holders |
| Q2 2021 | 33,774 | $464.0K | <0.1% | +33,774 | New | Holders |